Advertisement

Subacute Cutaneous and Systemic Lupus Erythematosus

  • Donna M. Pellowski
  • Jane E. Kihslinger
  • Richard D. Sontheimer

Keywords

Systemic Lupus Erythematosus Cutaneous Lupus Erythematosus Porphyria Cutanea Tarda Subacute Cutaneous Lupus Erythematosus Epidermolysis Bullosa Acquisita 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC (1982) Interrelationships of HLA-DR, MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 25: 1031–1040PubMedGoogle Scholar
  2. Amato L, Coronella G, Berti S, Moretti S, Fabbri P (2003) Subacute cutaneous lupus erythematosus in childhood. Pediatric Dermatol 20(1):31–4Google Scholar
  3. Ashworth J (1992) Subacute cutaneous lupus erythematosus in a patient with Crohn’s disease. Clin Exp Dermatol 17: 135–136PubMedGoogle Scholar
  4. Azurdia RM, Pagliaro JA, Diffey BL, Rhodes LE (1999) Sunscreen application by photosensitive patients is inadequate for protection. Br J Dermatol 140: 255–258PubMedGoogle Scholar
  5. Balbanova MB, Botev IN, Michailoba JI (1997) Subacute cutaneous lupus erthematosus induced by radiation therapy. Br J Dermatol 137: 648–649PubMedGoogle Scholar
  6. Bangert JL, Freeman RG, Sontheimer RD, Gilliam JN (1984) Comparative histopathology of subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Arch Dermatol 120: 332CrossRefPubMedGoogle Scholar
  7. Barilla-LaBarca ML, Atkinson JP (2000) Rheumatic syndromes associated with complement deficiency. Current Opinion in Rheumatol 15: 55–60CrossRefGoogle Scholar
  8. Bell DA, Maddison PJ (1980) Serologic subsets in systemic lupus erythematosus. Arthritis Rheum 23: 1268–1273PubMedGoogle Scholar
  9. Bielsa I, Herrero C, Font J, Mascaro JM (1987) Lupus erythematosus and toxic epidermal necrolysis. J Am Acad Dermatol 16: 1265–1267PubMedGoogle Scholar
  10. Black DR, Hornung CA, Schneider PD, Callen JP (2002) Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol 138(9): 1175–8CrossRefPubMedGoogle Scholar
  11. Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH (2001) Etanercept-induced subacute cutaneous lupus erythematosus Rheumatology 40(11): 1317–9CrossRefPubMedGoogle Scholar
  12. Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18: 59–62CrossRefPubMedGoogle Scholar
  13. Bohm M, Gaubitz M, Luger TA, Metze D, Bonsmann G (2003) Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus — A report of three cases. Dermatology 207:381–385CrossRefPubMedGoogle Scholar
  14. Bonsmann, G., Schiller M, Luger TA, and Stander S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44: 925–931.CrossRefPubMedGoogle Scholar
  15. Brenner S, Golan H, Gat A, Bialy-Golan A (1997) Paraneoplastic subacute cutaneous lupus erythematosus: report of a case associated with cancer of the lung. Dermatology 194: 172–174PubMedGoogle Scholar
  16. Brogan BL, Olsen NJ (2003) Drug-induced rheumatic syndromes. Curr Opin Rheumatol. 15(1):76–80.CrossRefPubMedGoogle Scholar
  17. Brooke R, Coulson IH, al-Dawoud A (1998) Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 139: 1132–1133CrossRefPubMedGoogle Scholar
  18. Brown CW, Jr. and Deng JS (1995) Thiazide diuretics induce cutaneous lupus-like adverse reaction. J Toxicol Clin Toxicol 33:729–733.PubMedGoogle Scholar
  19. Buckley D and Bames L (1995) Childhood subacute cutaneous lupus erythematosus associated with homozygous complement 2 deficiency. Pediatr. Dermatol. 4: 327–30.Google Scholar
  20. Cai W, Maldonado M, Werth VP (2000) Differential effects of UVA1 and UVB on skin lesions of MRL/ipr lupus mice. (Abstract) J Invest Dermatol 114: 884Google Scholar
  21. Callen JP, Hodge SJ, Kulick KB, Stelzeer G, Buchino JJ (1987) Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency. Arch Dermatol 123: 66–70CrossRefPubMedGoogle Scholar
  22. Callen JP, Klein J (1988) Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in 72 patients. Arthritis Rheum 31: 1007–1013PubMedGoogle Scholar
  23. Callen JP, Roth DE, McGrath C, Dromgoole SH (1991a) Safety and efficacy of a broad-spectrum sunscreen in patients with discoid or subacute cutaneous lupus erythematosus. Cutis 47: 130–132, 135–136PubMedGoogle Scholar
  24. Callen JP, Spencer LV, Burruss JB, Holtman J (1991b) Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127: 515–522CrossRefPubMedGoogle Scholar
  25. Callen JP (1997) Management of antimalarial-refaractory cutaneous lupus erythematosus. Lupus 6: 203–208PubMedGoogle Scholar
  26. Callen JP, Hughes AP, and Kulp-Shorten C (2001) Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine — A report of 5 cases. Archives of Dermatology 137:1196–1198.PubMedGoogle Scholar
  27. Camp PB, Davis LS (1997) Coexistence of subacute cutaneous lupus erythematosus and porphyria cutanea tarda: a case report [letter; comment]. Cutis 59: 216EGoogle Scholar
  28. Caproni M, Cardinali C, Salvatore E, Fabbri P (2001) Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations Int J Dermatol 40(1): 59–62CrossRefPubMedGoogle Scholar
  29. Castenet J, Taillan B, Lacour JP, Garnier G, Perrin C, Ortonne JP (1995) Subacute cutaneous lupus erythematosus associated with Hodgkin’s disease. Clin Rheumatol 14: 692–694PubMedGoogle Scholar
  30. Chlebus E, Wolska H, Blaszczyk M, Jablonska S (1998) Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus — Diagnostic criteria and therapeutic options. J Am Acad Dermatol 38: 405–412PubMedGoogle Scholar
  31. Ciconte A, Mills AE, Shipley A, Marks R (2002) Subacute cutaneous lupus erythematosus presenting in a child Australasian J Dermatol 43(1):62–4Google Scholar
  32. Cohen LM, Tyring SK, Rády P, Callen JP (1992) Human papillomavirus type II in multiple squamous cell carcinomas in a patient with subacute cutaneous lupus erythematosus. J Am Acad Dermatol 26Suppl: 840–845PubMedGoogle Scholar
  33. Cohen MR, Crosby D (1994) Systemic disease in subacute cutaneous lupus erythematosus: A controlled comparison with systemic lupus erythematosus. J Rheumatol 21: 1665–1669PubMedGoogle Scholar
  34. Cohen S, Stastny P, Sontheimer RD (1986) Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 29: 421–425PubMedGoogle Scholar
  35. Cordoba-Guijarro S, Feal C, Dauden E, Fraga J, Garcia-Diez A (2000) Lupus erythematosus-like lesions in a carrier of X-linked chronic granulomatous disease J Euro Acad Dermatol & Venereol 14(5): 409–11Google Scholar
  36. Costner MI, Provost TT, and Sontheimer RD (2004) Lupus erythematosus. Chapter 2. In, Cutaneous Manifestations of Rheumatic Diseases. 2nd edition. Lippincott Williams and Wilkins, Philadelphia.Google Scholar
  37. Crowson AN, Magro CM (1997) Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Human Pathol 28: 67–73CrossRefGoogle Scholar
  38. Crovato F (1981) Clofazimine in the treatment of annular lupus erythematosus. Arch Dermatol 117: 249–250CrossRefGoogle Scholar
  39. Dauden E, Bartolome B, Pascual M, Fraga J, Garcia-Diez A (2001) Autoinvolutive photoexa-cerbated tinea corporis mimicking a subacute cutaneous lupus erythematosus Acta Dermato-Venereologica 81(2): 141–2CrossRefPubMedGoogle Scholar
  40. David-Bajar KM, Bennion SD, DeSpain JD, Golitz LE, Lee LA (1992) The clinical, histologic and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus. J Invest Dermatol 99: 251–257CrossRefPubMedGoogle Scholar
  41. David-Bajar KM, Davis BM (1997) Pathology, immunopathology and immunohistochemistry in cutaneous lupus erythematosus. Lupus 6: 145–157PubMedGoogle Scholar
  42. Davis BM, Gilliam JN (1984) Prognostic significance of subepidermal immune deposits in un-involved skin of patients with systemic lupus erythematosus: a 10-year longitudinal study. J Invest Dermatol 83: 242–247CrossRefPubMedGoogle Scholar
  43. De Silva BD, Plant W, Kemmett D (2001) Subacute cutaneous lupus erythematosus and life-threatening hypokalaemic tetraparesis: a rare complication Br J Dermatol 144(3): 622–4PubMedGoogle Scholar
  44. DeSpain J, Clark DP (1988) Subacute cutaneous lupus erythematosus presenting as erythroderma. J Am Acad Dermatol 19: 388–392PubMedGoogle Scholar
  45. Dowdy MJ, Nigra TP, Barth WF (1989) Subacute cutaneous lupus erthematosus during PUVA therapy for psoriasis: Case report and review of the literature. Arthritis Rheum 32: 343–346PubMedGoogle Scholar
  46. Drosos AA, Dimou GS, Siamopoulou-Mavridou A, Hatzis J, Moutsopoulos HM (1990) Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study. Ann Med Interne (Paris) 141: 421–424Google Scholar
  47. Duong DJ, Spigel GT, Moxley RT, Gaspari AA (1999) American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol 135: 1079–1087CrossRefPubMedGoogle Scholar
  48. Fautrel B, Foltz V, Frances C, Bourgeois P, Rozenberg S (2002) Regression of subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis treated with a biologic tumor necrosis factor alpha-blocking agent: comment on the article by Pisetsky and the letter from Aringer et al. Arthritis & Rheumatism 46(5): 1408–9Google Scholar
  49. Feldmann R, Salomon D, Saurat J-H (1994) The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 189: 425–427PubMedGoogle Scholar
  50. Fernandez-Diaz ML, Herranz P, Suarez-Marrero MC, Borbujo J, Manzano R, Casado M (1995) Subacute cutaneous lupus erythematosus associated with cilazapril [letter]. Lancet 345: 398CrossRefGoogle Scholar
  51. Fine RM (1989) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Int J Dermatol 28: 375–376PubMedGoogle Scholar
  52. Fishelson Z, Attali G, Mevorach D (2001) Complement and apoptosis. Molecular Immunol 38: 207–219.Google Scholar
  53. Flageul B, Wallach D, Cavelier-Balloy B, Bachelez H, Carsuzaa F, Dubertret L (2000) Thalidomide and thrombosis Annales de Dermatologie et de Venereolgie 127(2): 171–4Google Scholar
  54. Furner BB (1990a) Treatment of subacute cutaneous lupus erythematosus. Int J Dermatol 29: 542–547PubMedGoogle Scholar
  55. Furner BB (1990b) Subacute cutaneous lupus erythematosus response to isotretinoin. Int J Dermatol 29: 587–590PubMedGoogle Scholar
  56. Gange KW, Levene GM (1979) A distinctive eruption in patients receiving oxprenolol. Clin Exp Dermatol 4: 87–97PubMedGoogle Scholar
  57. Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135: 1124–1125CrossRefPubMedGoogle Scholar
  58. Georgala S, Katoulis AC, Hasapi V, Koumantaki-Mathioudaki E (1998) Thalidomide treatment for hypertrophic lupus erythematosus [letter]. Clin Exp Dermatology. 23: 141CrossRefGoogle Scholar
  59. Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4: 471–475PubMedGoogle Scholar
  60. Goette DK (1985) Sweet’s syndrome in subacute cutaneous lupus erythematosus. Arch Dermatol 121: 789–791CrossRefPubMedGoogle Scholar
  61. Goldberg JW, Lidsky MD (1984) Pulse methylprednisolone therapy for persistent subacute cutaneous lupus. Arthritis Rheum. 27: 837–838Google Scholar
  62. Goodfield M, Davison K, Bowden K (2004) Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE). J Dermatolog Treat. 15(1):46–50.CrossRefPubMedGoogle Scholar
  63. Gubinelli E, Cocuroccia B, and Girolomoni G (2003) Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg. February 10Google Scholar
  64. Gudat W, Bork K (1989) Hereditary angioedema associated with subacute cutaneous lupus erythematosus. Dermatologica 179: 211–213PubMedGoogle Scholar
  65. Gundmundsen K, Otridge B, Murphy GM (1992) Fulminant fatal lupus erythematosus. Br J Dermatol 126: 303–304PubMedGoogle Scholar
  66. Gupta G, Roberts DT (1999) Pulsed dye laser treatment of subacute cutaneous lupus erythematosus. Clin Exp Dermatol 24: 498–499CrossRefPubMedGoogle Scholar
  67. Haimowitz JE, McCauliffe DP, Seykora J, Werth V (2000) Annular erytherma of Sjogren’s syndrome in a white woman. J Am Acad Dermatol 42: 1069–1073CrossRefPubMedGoogle Scholar
  68. Hamilton RG, Harley JB, Bias WB, Roebber M, Reichlin M, Hochberg MC, Arnett FC (1988) Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 31(4):496–505PubMedGoogle Scholar
  69. Hanjani NM, Nousari CH (2002) Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement. Arch Dermatol 138(12): 1616–8CrossRefPubMedGoogle Scholar
  70. Harley JP, Reichlin M, Arnett FC, Alexander EL, Bias WB, Provost TT (1986) Gene interaction at the HLA-DQ locus enhances autoantibody production in primary Sjogren’s syndrome. Science 232: 1145–1147PubMedGoogle Scholar
  71. Herrero C, Bielsa I, Font J, Lozano F, Ericilla G, Lecha M, Ingelman M, Mascaro JM (1988) Subacute cutaneous lupus erythematosus: Clinical pathologic findings in 13 cases. J Am Acad Dermatol 19: 1057–1062PubMedGoogle Scholar
  72. Ho C, Shumack SP, Morris D (2001) Subacute cutaneous lupus erythematosus associated with hepatocellular carcinoma Australasian J Dermatol 42(2): 110–3CrossRefGoogle Scholar
  73. Hochedez P, Vasseur E, Staroz F, Morelon S, Roudier Pujol C, Saiag P (2001) Subacute cutaneous lupus gyratus repens Annales de Dermatologie et de Venereologie 128(3 Ptl): 244–6PubMedGoogle Scholar
  74. Holtman JH, Neustadt DH, Klein J, Callen JP (1990) Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol 17: 1222–1225PubMedGoogle Scholar
  75. Ilan Y, Ben Yehuda A (1991) Subacute cutaneous lupus associated with Hashimoto’s thyroiditis. Neth J Med 39: 105–107PubMedGoogle Scholar
  76. Jewell M, McCauliffe DP (2000) Cutaneous lupus erythematosus patients that smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42: 983–987CrossRefPubMedGoogle Scholar
  77. Johansen PB, Gran JT (1998) Ototoxicity due to hydroxychloroquine — report of two cases. Clin Exper Rheumatol 16: 472–474Google Scholar
  78. Johansson-Stephansson E, Koskimes S, Partanen J, Kariniemi AL (1989) Subacute cutaneous lupus erythematosus: Genetic markers and clinical and immunological findings in patients. Arch Dermatol 125: 791–796CrossRefPubMedGoogle Scholar
  79. Klein LR, Elmets CA, Callen JP (1995) Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A emissions from a photocopier. Arthritis Rheum 38: 1152–1156PubMedGoogle Scholar
  80. Kneitz C, Wilhelm M, Tony HP (2002) Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 206:519–27CrossRefPubMedGoogle Scholar
  81. Konstadoulakis MM, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, et al. (1993) Thyroid autoantibodies in the subsets of lupus erythematosus: Correlation with other autoantibodies and thyroid function. Thyroidol Clin Exp 5: 1–7PubMedGoogle Scholar
  82. Korb LC, Ahearn JM (1997) Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes — complement deficiency and systemic lupus erythematosus revisited. J Immunol 158: 4525–4528PubMedGoogle Scholar
  83. Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45(1): 86–95CrossRefPubMedGoogle Scholar
  84. Kuhn A, Sonntag M, Lehmann P, Megahed M, Vestweber D, Ruzicka T (2002a) Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus. Arch Dermatol Res 294:6–13.CrossRefPubMedGoogle Scholar
  85. Kuhn A, Specker C, Ruzicka T, Lehmann P (2002b) Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. J Am Acad Dermatol 46(4): 600–3CrossRefPubMedGoogle Scholar
  86. Lanham JG, Hughes GRV (1982) Antimalarial therapy in SLE. Clin Rheumat Disease 8: 279–299Google Scholar
  87. Lee LA, Roberts CM, Frank MB, McCubbin VR, Reichlin M (1994) The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 130: 1262–1268CrossRefPubMedGoogle Scholar
  88. Lee CW (1998) Prevalences of subacute cutaneous lupus erythematosus and epidermolysis bullosa acquisita among Korean/Oriental populations. Dermatology 197: 187PubMedGoogle Scholar
  89. Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation [see comments]. J Am Acad Dermatol 22: 181–187PubMedGoogle Scholar
  90. Leroy DA, Dompmartin A, Le Jean SGJLMJC, Deschamps P (1987) Toxidermie A L’aldactone a type d’erytheme annulaire centrifuge lupique. Ann Dermatol Venereol 114:1237–1240PubMedGoogle Scholar
  91. Lio D, Candore G, Colombo A, et al. (2001) A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum Immunol 62: 705–713.CrossRefPubMedGoogle Scholar
  92. Lipsker D, Dicesare MP, Cribier D, Grosshans E, Heid E (1998) The significance of the ‘dust-like particles’ pattern of immunofluorescence. Br J Dermatol 138: 1039–1042CrossRefPubMedGoogle Scholar
  93. Lyon CC, Blewitt R, Harrison PV (1998) Subacute cutaneous lupus erythematosus: Two cases of delayed diagnosis. Acta Derm Venereol 78: 57–59CrossRefPubMedGoogle Scholar
  94. M VanHees CL, Boom BW, Vermeer BJ, Daha MR (1992) Subacute cutaneous lupus erythematosus in a patient with inherited deficiency of the third component of complement. Arch Dermatol 128: 700–701CrossRefPubMedGoogle Scholar
  95. Maddison PJ (1999) Nature and nurture in systemic lupus erythematosus. Adv Exp Med Biol 455: 7–13PubMedGoogle Scholar
  96. Marmor MF, Carr RE, Easterbrook M, et al. (2002) Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Opthalmology 190: 1377–82.CrossRefGoogle Scholar
  97. Marmor, MF (2003) New American Academy of Ophthalmology recommendations on screening for hydroxychloroquine retinopathy. Arthritis and Rheumatism 48:1764CrossRefGoogle Scholar
  98. Marschalko M, Dobozy E, Daroczy J, Gyimesi E, Horvath A (1989) Subacute cutanous lupus erythematosus: A study of 15 cases. Orvosi Hetilap 130: 2623–2628PubMedGoogle Scholar
  99. Marzano AV, Kolesnikova LV, Gasparni G, Alessi E (1999) Dystrophic calcinosis cutis in subacute lupus. Dermatology 198: 90–92CrossRefPubMedGoogle Scholar
  100. Marzano AV, Borghi A, Mercogliano M, Facchetti M, Caputo R (2003a) Nitrendipine-induced subacute cutaneous lupus erythematosus. Eur. J. Dermatol. 13:213–216.CrossRefPubMedGoogle Scholar
  101. Marzano AV, Facchetti M, Alessi E (2003b) Poikilodermatous subacute cutaneous lupus erythematosus. Dermatology 207(3):285–90CrossRefPubMedGoogle Scholar
  102. Massone C, Parodi A, Rebora A (2000) Erythema multiforme-like subacute cutaneous lupus erythematosus: a new variety? Acta Dermato-Venereologica 80(4):308–9CrossRefPubMedGoogle Scholar
  103. McCormack LS, Elgart ML, Turner ML (1984) Annular subacute cutaneous lupus erythematosus responsive to Dapsone. J Am Acad Dermatol 11: 397–401PubMedGoogle Scholar
  104. McGrath H Jr, Scopelitis E, Nesbitt LT Jr (1990) Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy [letter]. Arthritis Rheum 33: 302–303PubMedGoogle Scholar
  105. McGrath H (1997) Prospects for UV-A1 therapy as a treatment modality in cutaneous lupus erythematosus and systemic LE. Lupus 6: 209–217PubMedGoogle Scholar
  106. Messenger AG, Church RE (1986) Subacute cutaneous lupus erythematosus and malabsorption. Br J Dermatol 115(supplement 30): 56–57Google Scholar
  107. Meymandi S, Wiseman MC, Crawford RI (2003) Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol 48(2 Suppl): S7–8CrossRefPubMedGoogle Scholar
  108. Millard TP, McGregor JM (2001) Molecular genetics of cutaneous lupus erythematosus. Clinical and Experimental Dermatol 26: 184–91CrossRefGoogle Scholar
  109. Millard TP, Kondeatis E, Cox A, Wilson AG, Grabczynska SA, Carey BS, Lewis CM, Khamashta MA, Duff GW, Hughes GR, Hawk JL, Vaughan RW, McGregor JM (2001a) A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo Br J Dermatol 145(2): 229–36CrossRefPubMedGoogle Scholar
  110. Millard TP, Kondeatis E, Vaughan RW, Lewis CM, Khamashta MA, Hughes GR, Hawk JL, McGregor JM (2001b) Polymorphic light eruption and the HLA DRB1*0301 extended haplotype are independent risk factors for cutaneous lupus erythematosus. Lupus 10(7): 473–9CrossRefPubMedGoogle Scholar
  111. Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K (1989) Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 21: 343–346PubMedGoogle Scholar
  112. Modley C, Wood D, Horn T (1989) Metastatic malignant melanoma arising from a common blue nevus in a patient with subacute cutaneous lupus erythematosus. Dermatologica 178: 171–175PubMedGoogle Scholar
  113. Molad Y, Weinberger A, David M, Garty B, Wysenbeek AJ, Pinkas J (1987) Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus. Isr J Med. Sci 23: 278–280PubMedGoogle Scholar
  114. Morgan KW, Callen JP (2001) Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine J Rheumatol 28(9): 2129–32PubMedGoogle Scholar
  115. Mutasim DF. (2003) Severe subacute cutaneous lupus erythematosus presenting with generalized erythroderma and bullae. J Am Acad Dermatol 48(6):947–9CrossRefPubMedGoogle Scholar
  116. Neri R, Mosca M, Bernacchi E, Bombardieri S (1999) A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with Dapsone. Lupus 8: 240–243CrossRefPubMedGoogle Scholar
  117. Ng PP, Tan SH, Koh ET, Tan T (2000) Epidemiology of cutaneous lupus erythematosus in a tertiary referral center in Singapore Australasian J Dermatol 41(4): 229–33CrossRefPubMedGoogle Scholar
  118. Nieboer C, Tak-Diamand Z, VanLeeuwen-Wallau AG (1988) Dust-like particles: a specific direct immunofluorescence pattern in subacute cutaneous lupus erythematosus. Br J Dermatol 118: 725–734PubMedGoogle Scholar
  119. Nived O, Johansen PB, Sturfelt G (1993) Standardized ultraviolet-A exposure provokes skin reaction in systemic lupus erythematosus. Lupus 2: 247–250PubMedGoogle Scholar
  120. Norris DA (1993) Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 100: 58S–68SCrossRefPubMedGoogle Scholar
  121. Nousari HC, Kimyai-Asadi A, Tausk FA (1998) Subacute cutaneous lupus erythematosus associated with beta interferon-la. Lancet 352: 1825–1826CrossRefGoogle Scholar
  122. Ordi-Ros J, Cortes F, Cucurull E, Maurin M, Bujan S, Vilardell M (2000) Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. Journal of Phycology 27: 1429–1433Google Scholar
  123. Orteu DH, Sontheimer RD, Dutz JP (2001) The pathophysiology of photosensitivity in lupus erythematosus. Photodermatol Photoimmunol Photomed 17:95–113.CrossRefPubMedGoogle Scholar
  124. Pantoja L, Gonzalez-Lopez MA, Bouso M, Alija A, Ortiz-Saracho J (2002) Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis. Scandinavian J Rheumatol 31(6): 377–9CrossRefGoogle Scholar
  125. Parodi A, Caproni M, Cardinali C, Bernacchi E, Fuligni A, De Panfilis G, Zane C, Papini M, Veller FC, Vaccaro M, Fabbri P, Bader U, Banyai M, Boni R, Burg G, Hafner J (2000) Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus — A review by the Italian Group of Immunodermatology. Dermatology 200: 6–10PubMedGoogle Scholar
  126. Parodi A, Romagnoli M, Rebora A (1989) Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide. Photodermatol 6(2):100–2.PubMedGoogle Scholar
  127. Parodi A, Rivara G, Guarrera M (1992) Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. JAMA 268: 51–52CrossRefPubMedGoogle Scholar
  128. Patri P, Nigro A, Rebora A (1985) Lupus erythematosus-like eruption from captopril. Acta Derm Venereol 65: 447–448PubMedGoogle Scholar
  129. Perrotta S, Locatelli F, La Manna A et al. (2002) Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus Br J of Haematol 116:465–7.Google Scholar
  130. Piette JC, Sbai A, Frances C (2002) Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus Lupus 11(2): 67–70Google Scholar
  131. Pramatarov K, Vassileva S, Miteva L (2000) Subacute cutaneous lupus erythematosus presenting with generalized poiklioderma. J Am Acad Dermatol 42: 286–288CrossRefPubMedGoogle Scholar
  132. Price P, Witt C, Allock D, et al. (1999) The genetic basis for the association of the 8.1 ancestral haplotype (Al, B8, DR3) with multiple immunopathological diseases. Immunological Reviews. 167: 257–74.PubMedGoogle Scholar
  133. Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34: 244–252PubMedGoogle Scholar
  134. Provost TT, Talal N, Bias W, Harley JB, Reichlin M, Alexander EL (1988) Ro/SS-A positive Sjogren’s/lupus erythematosus overlap patients are associated with the HLA-DR3 and/or DRW6 phenotypes. J Invest Dermatol 91: 369–371PubMedGoogle Scholar
  135. Racila DM, Sontheimer CJ, Sheffield A, Wismeski JJ, Racila E, Sontheimer RD, (2003) Homozygous single nucleotide polmorphism of the complement C1QA gene is associated with decreased levels of Clq in patients with subacute cutaneous lupus erythematosus. Lupus 12(2): 124–32CrossRefPubMedGoogle Scholar
  136. Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25: 1716–1719PubMedGoogle Scholar
  137. Rao BK, Coldiron BM, Freeman RF, Sontheimer RD (1990) Subacute cutaneous lupus erythematosus lesions progressing to morphea. J Am Acad Dermatol 23: 1019–1022PubMedGoogle Scholar
  138. Reed BJ, Huff JC, Jones SK, Orton DW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 103: 49–51PubMedGoogle Scholar
  139. Reichlin M (2000)ANA negative systemic lupus erythematosus sera revisited serologically Lupus 9(2): 116–9CrossRefPubMedGoogle Scholar
  140. Richardson TT, Cohen PR (2000) Subacute cutaneous lupus erythematosus: report of a patient who subsequently developed a meningioma and whose skin lesions were treated with isotretinoin. Cutis 66: 183–188PubMedGoogle Scholar
  141. Rihner M, McGrath H, Jr. (1992) Fluorescent light photosensitivity in patients with systemic lupus erythematosus. Arthritis Rheum 35: 949–952PubMedGoogle Scholar
  142. Ross S, Dywer C, Ormerod AD, Herriot R, Roberts C (2002) Subacute cutaneous lupus erythematosus associated with phenytoin. Clinical & Experimental Dermatology 27:474–476Google Scholar
  143. Roura M, Lopez-Gil F, Umbert P (1991) Systemic lupus erythematosus exacerbated by piroxicam. Dermatologica 182:56–58.PubMedGoogle Scholar
  144. Roustan G, Salas C, Barbadillo C, Sanchez Yus E, Mulero J, Simon A (2000) Lupus erythematosus with an erythema multiforme-like eruption Eur J Dermatol 10: 459–462PubMedGoogle Scholar
  145. Rowell NR, Swanson-Beck J, Andrson JR (1963) Lupus erythematosus and erythema multi-forme-like lesions. Arch Dermatol 88: 176–180PubMedGoogle Scholar
  146. Rua-Figueroa I, Erausquin C, Naranjo A, Carretero-Hemandez G, Rodriguez-Lozano C, De la RP (1999) Pustuloderma during cutaneous lupus treatment with thalidomide [letter]. Lupus 8: 248–249CrossRefPubMedGoogle Scholar
  147. Rubin, RL (2002) Drug-Induced Lupus. In Dubois’ Lupus Erythematosus. D.J. Wallace and B.H. Hahn, editors. Lippincott Williams and Wilkins, Philadelphia.Google Scholar
  148. Rudnicka L, Szymanska E, Walecka I, Slowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus: a report of three cases. Dermatology 200: 129–131CrossRefPubMedGoogle Scholar
  149. Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. (2003) Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 149(1):131–7CrossRefPubMedGoogle Scholar
  150. Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil Br J Dermatol 147(1): 174–8CrossRefPubMedGoogle Scholar
  151. Scheinman PL (1994) Acral subacute cutaneous lupus erythematosus: an unusual variant. J Am Acad Dermatol 30: 800–801PubMedGoogle Scholar
  152. Schulz EJ, Menter MA (1971) Treatment of discoid and subacute cutaneous lupus erythematosus with cyclophosphamide. Br J Dermatol 85: 60–65Google Scholar
  153. Sheretz EF (1988) Lichen planus following procainamide inducedlupus erythematosus. Cutis 42: 51–53PubMedGoogle Scholar
  154. Siamopoulou-Mavridou A, Stefanou D, Dross AA (1989) Subacute lupus erythematosus childhood. Clin. Rheum. 8: 533–7.CrossRefGoogle Scholar
  155. Sonnichsen N, Meffert H, Kunzelmann V, Audring H (1993) [UV-A-1 therapy of subacute cutaneous lupus erythematos us]. [German]. Hautarzt 44: 723–725PubMedGoogle Scholar
  156. Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A. (2003) Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology 206(4): 326–9CrossRefPubMedGoogle Scholar
  157. Sontheimer RD, Gilliam JN (1979) A reappraisal of the relationship between subepidermal immunoglobulin deposits and DNA antibodies in systemic lupus erythematosus: a study using the Crithidia luciliae immunofluorescence anti-DNA assay. J Invest Dermatol 72: 29–32CrossRefPubMedGoogle Scholar
  158. Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinctlupus erythematosus subset. Arch Dermatol 115: 1409–1415CrossRefPubMedGoogle Scholar
  159. Sontheimer RD, Stastny P, Gilliam JN (1981) Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. J Clin Invest 67: 312–316PubMedGoogle Scholar
  160. Sontheimer RD, Maddison PJ, Reichlin M, Jordan RE, Stastny P, Gilliam JN (1982) Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 97: 644–671Google Scholar
  161. Sontheimer RD (1985) Clinical significance of subacute cutaneous lupus erythematosus skin lesions. J Dermatol 12: 205–212PubMedGoogle Scholar
  162. Sontheimer RD (1989) Subacute cutaneous lupus erythematosus: a decade’s perspective. Med Clin North Am 73: 1073PubMedGoogle Scholar
  163. Sontheimer RD, Provost TT (1996) Lupus erythematosus. In Sontheimer RD, Provost TT (eds) Cutaneous Manifestations of Rheumatic Diseases. Williams and Wilkins, Baltimore, p 31Google Scholar
  164. Srivastava, M, Rencic A, Diglio G, Santana H, Bonitz P, Watson R, Ha E, Anhalt GJ, Provost TT, Nousari CH (2003) Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 139:45–49.CrossRefPubMedGoogle Scholar
  165. Stege H, Budde MA, Grether-Beck S, Krutmann J (2000) Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test Photodermatol, Photoimmunol, & Photomed 16(6): 256–9Google Scholar
  166. Stevens RJ, Andujar C, Edwards CJ, Ames PR, Barwick AR, Khamashta MA, Hughes GR (1997) Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 36: 353–359CrossRefPubMedGoogle Scholar
  167. Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6: 96–104PubMedGoogle Scholar
  168. Tebbe B, Mansmann U, Wollina U, Auergrumbach P, Lichtmbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement — A multicenter study on 296 patients. Acta Dermato-Venereol 77: 305–308Google Scholar
  169. Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B (1990) Recombinant interferon a2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 122: 405–409PubMedGoogle Scholar
  170. Ting W, Sontheimer RD (2001) Local therapy for cutaneous LE and systemic LE: Practical and theoretical consideration. Lupus 10: 171–189CrossRefPubMedGoogle Scholar
  171. Toll A, Campo-Pisa P, Gonzalez-Castro J, Campo-Voegeli A, Azon A, Iranzo P, Lecha M, Herrero C (1998) Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus 7: 364–366CrossRefPubMedGoogle Scholar
  172. Topaloglu R, Bakkaloglu A, Slingsby JH et al. (2000) Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency. Clinical and Experimental Rheumatol 18:75–77Google Scholar
  173. Trenholme GM, Carson PE (1978) Therapy and prophylaxis of malaria. JAMA 240: 2293–229CrossRefPubMedGoogle Scholar
  174. Valeski JE, Kumar V, Forman AB, Beutner EH, Chorzelski TP (1992) J Am Acad Derm 27: 194–198PubMedGoogle Scholar
  175. Vasquez-Doval J, Ruiz de Erenchun F, Sanchz-Ibarrola A, Contrera F, Soto de Delas J, Quintanilla E (1992) Subacute cutaneous lupus erythematosus — clinical, histopathological and immunophenotypical study of five cases. J Invest Allerg 2: 27–32Google Scholar
  176. Velthuis PJ, Kater L, Van der Tweel I, Baart de la Faille H, Van Vloten WA (1992) Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: More than just the lupus band. Ann Rheum Dis 51: 720–725PubMedGoogle Scholar
  177. Walport MJ, Davies KA, Botto M (1998) Clq and systemic lupus erythematosus. Immunobiol 199: 265–85PubMedGoogle Scholar
  178. Warren KJ, Nopper AJ, Crosby DL (1998) Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus. J Am Acad Dermatol 39: 293–295PubMedGoogle Scholar
  179. Watson RM, Talwar P, Alexander E, Bias WB, Provost TT (1991) Subacute cutaneous lupus erythematosus-immunogenetic associations. J Autoimmun 4: 73–85CrossRefPubMedGoogle Scholar
  180. Wenzel J, Bauer R, Bieber T, Bohm I (2000) Autoantibodies in patients with lupus erythematosus: spectrum and frequencies Dermatology 201(3): 282–3CrossRefPubMedGoogle Scholar
  181. Wenzel J, Bauer R, Uerlich M, Bieber T, Boehm I (2002) The value of lymphocytopenia as a marker of systemic involvement in cutaneous lupus erythematosus Br J Dermatol 146(5): 869–71CrossRefPubMedGoogle Scholar
  182. Werth VP, Zhang W, Dortzbach K, Sullivan, K (2000) Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 115: 726–730CrossRefPubMedGoogle Scholar
  183. Wollina U, Barta U, Uhlemann C, Oelzner P (1999) Lupus erythematosus-associated red lunula. J Am Acad Dermatol 41: 419–421PubMedGoogle Scholar
  184. Wollina U, Schreiber G (2003) Polyglandular autoimmune syndrome type II (Schmidt’s syndrome) in patients with autoimmune connective tissue disorders. J Eur Acad Derm Venereol 17(3): 371–2CrossRefGoogle Scholar
  185. Yung RL, Richardson BC (1995) Cytarabine therapy for refractory cutaneous lupus. Arthritis Rheum 38:1341–1343PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Donna M. Pellowski
  • Jane E. Kihslinger
  • Richard D. Sontheimer

There are no affiliations available

Personalised recommendations